Prenatal screens: blood type O positive, antibody negative, RPR nonreactive, rubella immune, hepatitis B surface antigen negative, and GBS unknown.
Pregnancy noted for prophylactic cerclage placed at 12 weeks and also complicated by spontaneous premature rupture of membranes on [**10-25**] prompting maternal admission and monitoring.
She was treated with magnesium for several days for contractions which were discontinued on [**10-26**].
Course of betamethasone was complete on [**10-27**] and 7 days of ampicillin and erythromycin were completed on [**11-1**].
Therefore she was taken for repeat cesarean section due to increasing concerns for chorioamnionitis.
Responded well to stimulation and positive pressure ventilation She was intubated in the delivery room and was transferred to the newborn intensive care unit for further management.
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  RESPIRATORY: [**Known lastname **] was intubated in the delivery room for management of prematurity and respiratory distress.
She is status post surfactant therapy, status post right chest tube placement on day of life 1 secondary to pneumothorax.
She extubated to CPAP on day of life 51 and to nasal cannula oxygen on day of life 78 where she continues on nasal cannula 125 cc per minute of 100% oxygen.
The infant was started on caffeine early on in her course.
Her caffeine citrate was discontinued on [**12-30**].
She was started on Diuril on [**11-5**].
She was started on Lasix every other day.
On [**1-31**] she was started on aldactone on [**2-10**].
She continues on her Diuril, Lasix and aldactone.
CARDIOVASCULAR: She was treated with indomethacin for a patent ductus arteriosis on day of life 2.An echocardiogram on [**2135-2-25**], per pulmonary request revealed no patent ductus arteriosus, a small patent foramen ovale, no pulmonary hypertension, and a structurally normal heart.
Enteral feedings were started on day of life 8 and advaned to full enteral feedings by day of life18.
She was started on potassium supplementation secondary to losses due to diuretic therapy.
She continues on potassium supplements.
GASTROINTESTINAL: She was started on Zantac on [**2-15**] due to gastroesophageal reflux symptoms and continues on Zantac to date.
She had multple packed red blood cell transfusions, most recently on [**2135-1-19**].
She continues on ferrous sulfate supplementation.
INFECTIOUS DISEASE: She was started on  ampicillin and gentamycin at the time of admission for sepsis risk factors.
OPHTHALMOLOGY: [**Known lastname **] is status post bilateral laser therapy for retinopathy of prematurity.
Feeds at discharge: Continue ad lib breast milk 24     calorie concentrated with 4 calories of Similac powder.
Medications: Ferrous sulfate(25 mg/ml)0.4 ml once daily     Zantac7.6 mg q 8 hours     Lasix 3.8 mg every other day     Diuril 76 mg q12 hours     Aldactone 7.6 mg once daily     Potassium Chloride supplementation 4 mEqs q12 hours.
Immunizations received:     Synagisn [**2-3**], and [**2-26**]     Hepatitis B vaccine on [**2134-12-2**]     Pediarix on [**2135-1-2**]     HIB on [**2135-1-2**],     Pneumococcal vaccine on [**2135-1-2**].
Immunizations recommended: Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following three criteria.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out of home caregivers.
Early Intervention 5.
Status post right pneumothorax.
Status post patent ductus arteriosus.
Status post grade 3 intraventricular hemorrhage.
Status post bilateral laser therapy for retinopathy of     prematurity.
Status post hyperbilirubinemia of prematurity 12.Gastro-esophageal reflux 13, Status post apnea of prematurity                           [**First Name11 (Name Pattern1) 449**] [**Last Name (NamePattern1) **], [**MD Number(1) 54604**]  Dictated By:[**Last Name (NamePattern1) **] MEDQUIST36 D:  [**2135-2-27**] 22:16:11 T:  [**2135-2-28**] 01:53:47 Job#:  [**Job Number 66135**]
